Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...
UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...
Zacks.com on MSN2d
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...
UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...
Amedisys (NASDAQ:AMED – Get Free Report ... It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes ...
Regent Surgical ("Regent"), a leading partner to health systems and physician practices, specializing in the development and management of ambulatory surgery centers (ASCs), has expanded its c-suite, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback